Applied Therapeutics (APLT) Major Shareholder Buys $9,750,000.00 in Stock

Applied Therapeutics (NASDAQ:APLT) major shareholder Real Estate Equitie Alexandria acquired 975,000 shares of Applied Therapeutics stock in a transaction dated Thursday, May 16th. The shares were purchased at an average cost of $10.00 per share, with a total value of $9,750,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

APLT stock opened at $10.01 on Tuesday.

WARNING: This report was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at

Applied Therapeutics Company Profile

Applied Therapeutics, Inc, a biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-001 that is in phase II clinical trials for treating diabetic cardiomyopathy, as well as is in phase I clinical trials to treat diabetic peripheral neuropathy.

Featured Story: Correction

Receive News & Ratings for Applied Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Therapeutics and related companies with's FREE daily email newsletter.